US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist

1.770
-2.200-55.42%

Close Dec 13 16:00 ET

1.840
+0.070+3.95%

Post 19:56 ET

75.24MMarket Cap-0.89P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Repare Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 2.341M	--
--	2024/Q4	-- / 2.733M	--
--	2024/Q3	0.000 / 2.733M	--
--	2024/Q2	1.073M / 2.929M	--
--	2024/Q1	52.404M / 38.400M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 2.341M--

--2024/Q4-- / 2.733M--

--2024/Q30.000 / 2.733M--

--2024/Q21.073M / 2.929M--

--2024/Q152.404M / 38.400M--

Unlock Free Earnings Estimates

Open Account

Repare Therapeutics Earnings Reports

Repare Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 07:18 ET

Repare Therapeutics | 8-K: Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results

Nov 7 07:13 ET

Repare Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6 16:24 ET

Repare Therapeutics | 8-K: Repare Therapeutics Provides Business and Clinical Update and Reports Second Quarter 2024 Financial Results

Aug 6 16:15 ET

Analyst Rating

Updated: Dec 13, 2024

Buy

Buy
66.67%
Hold
33.33%
Sell
0.00%

Price Target

No Data

Heat List

Overall